STAT+: Key Senate committee proposes a council to ensure FDA better coordinates on accelerated approvals

[ad_1]

WASHINGTON — The Senate is taking pains to avoid another Aduhelm controversy.

In new bipartisan legislation unveiled on Friday, senators included language that would create a “coordinating council” meant to ensure officials across the entire Food and Drug Administration stay in sync when considering medicines under the controversial accelerated approval pathway.

Continue to STAT+ to read the full story…

[ad_2]

Source link

AsadKhan92

Learn More →

Leave a Reply

Your email address will not be published.